|
Volumn 90, Issue 3, 2003, Pages 637-643
|
First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
PACLITAXEL;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
DOSE RESPONSE;
FEMALE;
FOLLOW UP;
HUMAN;
INFUSION;
INFUSION PUMP;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
OVARY TUMOR;
PATHOLOGY;
RETROSPECTIVE STUDY;
SECOND LOOK SURGERY;
TUMOR RECURRENCE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSION PUMPS, IMPLANTABLE;
INFUSIONS, PARENTERAL;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PACLITAXEL;
RETROSPECTIVE STUDIES;
SECOND-LOOK SURGERY;
|
EID: 0141940295
PISSN: 00908258
EISSN: None
Source Type: Journal
DOI: 10.1016/S0090-8258(03)00377-9 Document Type: Article |
Times cited : (86)
|
References (0)
|